A COVID-19 first evaluation clinic at a university hospital in Turkey

Background/aim: We aimed to analyze the usefulness of such a reserved area for the admission of the patients’ symptoms suggesting COVID-19 and compare the demographic and clinical characteristics of the patients with COVID-19 and without COVID-19 who were admitted to C1 during the first month of the COVID-19 outbreak in our hospital. Materials and methods: A new area was set up in Hacettepe University Adult Hospital to limit the contact of COVID-19 suspicious patients with other patients, which was named as COVID-19 First Evaluation Outpatient Clinic (C1). C1 had eight isolation rooms and two sampling rooms for SARS-CoV-2 polymerase-chain-reaction (PCR). All rooms were negative-pressurized. Patients who had symptoms that were compatible with COVID-19 were referred to C1 from pretriage areas. All staff received training for the appropriate use of personal protective equipment and were visited daily by the Infection Prevention and Control team. Results: One hundred and ninety-eight (29.4%) of 673 patients who were admitted to C1were diagnosed with COVID-19 between March 20, 2020, and April 19, 2020. SARS-CoV-2 PCR was positive in 142 out of 673 patients. Chest computerized tomography (CT) was performed in 421 patients and COVID-19 was diagnosed in 56 of them based on CT findings despite negative PCR. Four hundred and ninety-three patients were tested for other viral and bacterial infections with multiplex real-time reverse-transcriptase PCR (RTPCR). Blood tests that included complete blood count, renal and liver functions, d-dimer levels, ferritin, C- reactive protein, and procalcitonin were performed in 593 patients. Only one out of 44 healthcare workers who worked at C1 was infected by SARS-CoV-2. Conclusion: A well-planned outpatient care area and teamwork including internal medicine, microbiology, and radiology specialists under the supervision of infectious diseases specialists allowed adequate management of the mild-to-moderate patients with suspicion of COVID-19.

PDF

___

1.Phelan, A.L., R. Katz, and L.O. Gostin, The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. Journal of the American Medical Association, 2020. 323(8): p. 709-710.DOI: 10.1001/jama.2020.1097
2.Coronaviridae Study Group of the International Committee on Taxonomy of, V., The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 2020. 5(4): p. 536-544.DOI: 10.1038/s41564-020-0695-z
3.Cascella, M., M. Rajnik, A. Aleem, S.C. Dulebohn, and R. Di Napoli, Features, Evaluation, and Treatment of Coronavirus (COVID-19), in StatPearls Publishing. 2021: Treasure Island (FL).
4.Guan, W.J., Z.Y. Ni, Y. Hu, W.H. Liang, C.Q. Ou et al. Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine, 2020. 382(18): p. 1708- 1720.DOI: 10.1056/NEJMoa2002032
5.Wu, Z. and J.M. McGoogan, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. Journal of the American Medical Association, 2020. 323(13): p. 1239-1242.DOI: 10.1001/jama.2020.2648
6.Chung, H.S., D.E. Lee, J.K. Kim, I.H. Yeo, C. Kim et al. Revised Triage and Surveillance Protocols for Temporary Emergency Department Closures in Tertiary Hospitals as a Response to COVID-19 Crisis in Daegu Metropolitan City. Journal of Korean Medical Sciences, 2020. 35(19): p. e189.DOI: 10.3346/ jkms.2020.35.e189
7.Augustin, M., P. Schommers, I. Suarez, P. Koehler, H. Gruell et al. Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Euro Surveill, 2020. 25(21).DOI: 10.2807/1560-7917. ES.2020.25.21.2000531
8.Kim, Y.J., J.Y. Choe, K.T. Kwon, S. Hwang, G.S. Choi et al. How to keep patients and staff safe from accidental SARS-CoV-2 exposure in the emergency room: Lessons from South Korea’s explosive COVID-19 outbreak. Infection Control&Hospital Epidemiolgy, 2021. 42(1): p. 18-24.DOI: 10.1017/ice.2020.376
9.Uyaroğlu OA, C.B.N., Ozisik L., Tas, Z., Telli-Dizman G., İnkaya A.C., Alp S., Durusu Tanrıover M., Metan G, Sain Guven G, First Confirmed Cases of 2019 Novel Coronavirus in a University Hospital in Turkey: Housemate Internists. Acta Medica 2020. 51.
10.Ayaz, C.M., G.T. Dizman, G. Metan, A. Alp, and S. Unal, Outpatient management of patients with COVID-19 on home isolation. Le Infezioni in Medicina, 2020. 28(3): p. 351-356.
11.Li, X., S. Xu, M. Yu, K. Wang, Y. Tao et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunolgy, 2020. 146(1): p. 110-118. DOI: 10.1016/j.jaci.2020.04.006
12.Piroth, L., J. Cottenet, A.S. Mariet, P. Bonniaud, M. Blot et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, populationbased retrospective cohort study. The Lancet Respiratory Medicine, 2021. 9(3): p. 251-259.DOI: 10.1016/S2213- 2600(20)30527-0
13.Novelli, L., F. Raimondi, A. Ghirardi, D. Pellegrini, D. Capodanno et al. At the peak of COVID-19 age and disease severity but not comorbidities are predictors of mortality: COVID-19 burden in Bergamo, Italy. Panminerva Medica, 2021. 63(1): p. 51-61. DOI: 10.23736/S0031-0808.20.04063-X
14.Munoz, P., A. Galar, P. Catalan, M. Valerio, T. Aldamiz-Echevarria et al. The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up. Revista Espanola de Quimioterapia, 2020. 33(5): p. 369-378.DOI: 10.37201/req/072.2020
15.Yang, J., Y. Zheng, X. Gou, K. Pu, Z. Chen et al. Prevalence of comorbidities and its effects in patients infected with SARSCoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases, 2020. 94: p. 91-95.DOI: 10.1016/j.ijid.2020.03.017
16.Zhang, J.J.Y., K.S. Lee, L.W. Ang, Y.S. Leo, and B.E. Young, Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, MetaAnalysis, and Meta-Regression Analysis. Clinical Infectious Diseases, 2020. 71(16): p. 2199-2206.DOI: 10.1093/cid/ciaa576
17.Patrucco, F., A. Carriero, Z. Falaschi, A. Pasche, F. Gavelli et al. COVID-19 Diagnosis in Case of Two Negative Nasopharyngeal Swabs: Association between Chest CT and Bronchoalveolar Lavage Results. Radiology, 2021. 298(3): p. E152-E155.DOI: 10.1148/radiol.2020203776
18.Wang, D., B. Hu, C. Hu, F. Zhu, X. Liu et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel CoronavirusInfected Pneumonia in Wuhan, China. Journal of the American Medical Association, 2020. 323(11): p. 1061-1069. DOI: 10.1001/jama.2020.1585
19.Zhou, F., T. Yu, R. Du, G. Fan, Y. Liu et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020. 395(10229): p. 1054-1062.DOI: 10.1016/S0140- 6736(20)30566-3
20.Wu, C., X. Chen, Y. Cai, J. Xia, X. Zhou et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. Journal of the American Medical Association Internal Medicine, 2020. 180(7): p. 934-943.DOI: 10.1001/ jamainternmed.2020.0994
21.Langford, B.J., M. So, S. Raybardhan, V. Leung, D. Westwood et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection, 2020. 26(12): p. 1622-1629.DOI: 10.1016/j.cmi.2020.07.016
22.Giacomelli, A., A.L. Ridolfo, L. Oreni, S. Vimercati, M. Albrecht et al. Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? Pharmacological Research, 2021. 164: p. 105403.DOI: 10.1016/j.phrs.2020.105403
23.Seabra, G., R.F. Ventura Mendes, L.F.V. Dos Santos Amorim, I.V. Peregrino, M.H. Branquinha, et al. Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance. Current Topics in Medicinal Chemistry, 2021. 21(8): p. 677-683.DOI: 10.2174/156802662108210319145317
24.Hamade, B. and D.T. Huang, Procalcitonin: Where Are We Now? Critical Care Clinics, 2020. 36(1): p. 23-40.DOI: 10.1016/j. ccc.2019.08.003
25.Povoa, P., L. Coelho, E. Almeida, A. Fernandes, R. Mealha et al. C-reactive protein as a marker of infection in critically ill patients. Clinical Microbiology and Infection, 2005. 11(2): p. 101-108.DOI: 10.1111/j.1469-0691.2004.01044.x
26.Velavan, T.P. and C.G. Meyer, Mild versus severe COVID-19: Laboratory markers. International Journal of Infection Diseases, 2020. 95: p. 304-307.DOI: 10.1016/j.ijid.2020.04.061
27.Sieswerda, E., M.G.J. de Boer, M.M.J. Bonten, W.G. Boersma, R.E. Jonkers, et al. Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline. Clinical Microbiology and Infection, 2021. 27(1): p. 61-66.DOI: 10.1016/j.cmi.2020.09.041
28.Wu, D., J. Lu, Z. Sun, L. Cao, Q. Zeng et al. Rhinovirus remains prevalent in school teenagers during fight against COVID-19 pandemic. Immunty Inflammation and Disease, 2021. 9(1): p. 76-79.DOI: 10.1002/iid3.381